91. バッド・キアリ症候群 Budd-Chiari syndrome Clinical trials / Disease details

臨床試験数 : 4 / 薬物数 : 5 - (DrugBank : 4) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 14

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100046725	2022-01-01	2021-05-27	The efficacy and safety of Warfarin and Rivaroxabanto prevent re-occlusion for Budd-Chiari syndrome ...	To compare the efficacy and safety of Warfarin and Rivaroxabanto prevent re-occlusion for Budd-Chiar ...	Budd-Chiari syndrome	Warfarin group:oral take Warfarin;Rivaroxaban group:oral take rivaroxaban;	The First Affiliated Hospital of Zhengzhou University	NULL	Recruiting	18	75	Both	Warfarin group:40;Rivaroxaban group:40;	N/A	China
2	EUCTR2014-005162-29-NL (EUCTR)	09/04/2020	13/06/2019	Treatment of thrombosis in the abdominal veins	Treatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective ...	Splanchnic vein thrombosis (SVT) is an unusual site manifestation of venous thromboembolism (VTE). I ...	Trade Name: rivaroxaban 20 mg Product Name: rivaroxaban	University of Insubria	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 4	France;Canada;Germany;Netherlands;Italy

First Previous1Next Last